Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
5.17
+0.22 (4.44%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Elicio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
--35.2-28.21-26.4-15.71
Upgrade
Depreciation & Amortization
-1.171.060.250.19
Upgrade
Loss (Gain) From Sale of Assets
-0.110--
Upgrade
Stock-Based Compensation
-1.180.580.620.3
Upgrade
Other Operating Activities
-0.14.540.720.05
Upgrade
Change in Accounts Payable
-0.021.130.031.12
Upgrade
Change in Other Net Operating Assets
--0.08-1.280.84-2.66
Upgrade
Operating Cash Flow
--32.69-22.18-23.94-16.7
Upgrade
Capital Expenditures
--0.07-0.65-0.53-0.2
Upgrade
Sale of Property, Plant & Equipment
-0.03---
Upgrade
Investing Cash Flow
--0.03-0.65-0.53-0.2
Upgrade
Short-Term Debt Issued
---14.68-
Upgrade
Long-Term Debt Issued
-10---
Upgrade
Total Debt Issued
-10-14.68-
Upgrade
Net Debt Issued (Repaid)
-10-14.68-
Upgrade
Issuance of Common Stock
-7.130.080.210.25
Upgrade
Repurchase of Common Stock
--0.15---
Upgrade
Other Financing Activities
-21.64--0.44-
Upgrade
Financing Cash Flow
-38.6121.219.3925.06
Upgrade
Net Cash Flow
-5.89-1.63-5.078.16
Upgrade
Free Cash Flow
--32.76-22.83-24.46-16.9
Upgrade
Free Cash Flow Per Share
--6.48-72.26-1.60-1.57
Upgrade
Levered Free Cash Flow
--16.93-20.49-12.51-8.02
Upgrade
Unlevered Free Cash Flow
--16.27-18.24-11.96-8.02
Upgrade
Change in Net Working Capital
-3.05-3.794.39-3.62-1.51
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q